Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 1998
Higher levels of thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma
R Gorlick, R Metzger, K D Danenberg, et al.
The Journal of Surgical Research
|
July 27, 2001
Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma
J Brabender, R V Lord, K D Danenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 1998
ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy
R Metzger, C G Leichman, K D Danenberg, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
May 2, 2001
Upregulation of ornithine decarboxylase mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma
J Brabender, R V Lord, K D Danenberg, et al.
The Pharmacogenomics Journal
|
June 6, 2012
Intratumoral expression profiling of genes involved in angiogenesis in colorectal cancer patients treated with chemotherapy plus the VEGFR inhibitor PTK787/ZK 222584 (vatalanib)
P M Wilson, D Yang, M Azuma, et al.
The Pharmacogenomics Journal
|
January 11, 2012
Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapy
A Pohl, A El-Khoueiry, D Yang, et al.
Cancer Research
|
October 4, 2000
Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma
C A Eads, R V Lord, S K Kurumboor, et al.
Surgery
|
March 7, 2001
Retinoic acid receptor-alpha messenger RNA expression is increased and retinoic acid receptor-gamma expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence
R V Lord, P I Tsai, K D Danenberg, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
February 16, 2000
Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence
R V Lord, D Salonga, K D Danenberg, et al.
Oncogene
|
June 29, 2001
Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival
J Brabender, H Usadel, K D Danenberg, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 1998
Higher levels of thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma
R Gorlick, R Metzger, K D Danenberg, et al.
The Journal of Surgical Research
|
July 27, 2001
Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma
J Brabender, R V Lord, K D Danenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 1998
ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy
R Metzger, C G Leichman, K D Danenberg, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
May 2, 2001
Upregulation of ornithine decarboxylase mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma
J Brabender, R V Lord, K D Danenberg, et al.
The Pharmacogenomics Journal
|
June 6, 2012
Intratumoral expression profiling of genes involved in angiogenesis in colorectal cancer patients treated with chemotherapy plus the VEGFR inhibitor PTK787/ZK 222584 (vatalanib)
P M Wilson, D Yang, M Azuma, et al.
The Pharmacogenomics Journal
|
January 11, 2012
Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapy
A Pohl, A El-Khoueiry, D Yang, et al.
Cancer Research
|
October 4, 2000
Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma
C A Eads, R V Lord, S K Kurumboor, et al.
Surgery
|
March 7, 2001
Retinoic acid receptor-alpha messenger RNA expression is increased and retinoic acid receptor-gamma expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence
R V Lord, P I Tsai, K D Danenberg, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
February 16, 2000
Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence
R V Lord, D Salonga, K D Danenberg, et al.
Oncogene
|
June 29, 2001
Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival
J Brabender, H Usadel, K D Danenberg, et al.
Page
of 6